Completing a COVID 19 article necessitates extensive study and the use of actual evidence. There is no evidence that the coronavirus disease (COVID-19) pandemic has had a major effect on human life all over the world, as well as many businesses. Although the direct effect of coronavirus is severe and continues to claim many human lives on a regular basis, the indirect effects of the virus, embodied in lockdowns, have increasingly devastated the world’s economy. In this respect, the healthcare sector is no different and is currently struggling, with current demand creating significant obstacles for healthcare professionals and the industry as a whole. The ongoing coronavirus pandemic became one of the most challenging crises the world has ever faced yet. With the damage that the virus does to some vital organs in the human body, the disease manages to take thousands of lives every day (“Weekly Updates by Select Demographic and Geographic Characteristics,” 2020). In addition, the variety of symptoms and even their frequent absence in patients diagnosed with coronavirus make the disease extremely hard to detect (Lu et al., 2020). Thus, the measures that are taken by most governments around the world, such as lockdowns, were absolutely necessary, despite their negative influence on economies and industries.
A relatively sudden economic shift downwards is, perhaps, the second biggest challenge that the ongoing pandemic has brought about. With the need to isolate people socially, nearly all governments around the world have taken very restricting, albeit needed measures, which, in turn, negatively affected the economies of those countries, with average yearly losses per capita varying between $5,000 and $33,000 (Coibion, Gordnichenko, & Weber, 2020). At the same time, many industries have suffered greatly on the international level regardless of the governmental support or the volumes of production at the time of the lockdowns’ start.
While tourism, travel, and transportation are, perhaps, the most affected ones, there are other industries that suffered greatly. Surprisingly, the pharmacological industry seems to have been damaged as well. Nayyereh Ayati, Parisa Saiyarsara, and Shekoufeh Nikfar (2020) report that due to the sharp rise of demand, pharmaceutical markets inevitably face significant shortages all around the world. At the same time, lots of drug manufacturers will have to largely diversify their efforts to fit in the renewed post-pandemic world, spending lots of funds towards the development of the vaccine and other means of treatment (Ayati, Saiyarsara, & Nikfar, 2020). However, the problems within the healthcare industry do not end at this point.
The operational issue is another great problem for the healthcare industry that emerged along with the coronavirus outbreak. While the demand for healthcare services gradually rises, the healthcare practitioners, being in the frontline of the virus exposure, also suffer from other problems. Many healthcare providers have reported suffering from post-traumatic stress disorder (PTSD) by the end of the first wave of the pandemic. At the same time, many practitioners become infected with coronavirus and eventually die (Leite, Lindsay, & Kumar, 2020). Just like with the pharmaceutical industry, healthcare operations face a serious issue of an extremely increased demand, which cannot be satisfied with the available resources. This means that further shortages and the inability to properly diagnose and treat the disease are imminent.
The coronavirus pandemic, thus, is one of the most serious problems the modern civilization faced yet. Although many industries seem to suffer a lot, healthcare is in the frontline and is, hence, the most affected from the perspectives of the physical well-being of the practitioners in the industry, as well as of economic downturn, with the vast shortages being projected since the end of the first wave of the pandemic. Yet, human civilization has always managed to adapt to a variety of crises, and the COVID-19 pandemic does not appear to be an exception.
Ayati, N., Saiyarsarai, P., & Nikfar, S. (2020). Short and long term impacts of COVID-19 on the pharmaceutical sector. DARU Journal Of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-020-00358-5
Coibion, O., Gorodnichenko, Y., & Weber, M. (2020). The Cost of the Covid-19 Crisis: Lockdowns, Macroeconomic Expectations, and Consumer Spending. National Bureau of Economic Research. Retrieved 27 November 2020, from https://www.nber.org/papers/w27141.
Leite, H., Lindsay, C., & Kumar, M. (2020). COVID-19 outbreak: implications on healthcare operations. The TQM Journal, ahead-of-print. https://doi.org/10.1108/tqm-05-2020-0111
Lu, S., Lin, J., Zhang, Z., Xiao, L., Jiang, Z., & Chen, J. et al. (2020). Alert for non‐respiratory symptoms of coronavirus disease 2019 patients in epidemic period: A case report of familial cluster with three asymptomatic COVID‐19 patients. Journal Of Medical Virology. https://doi.org/10.1002/jmv.25776
Weekly Updates by Select Demographic and Geographic Characteristics. Centers for Disease Control and Prevention. (2020). Retrieved from https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm.